How Denmark could struggle to separate its interests in EU pharma reform
Monday, 23 June 2025 ()
Poland, which advocated for European patients to have access to cutting-edge medicines faster, is wrapping up its Council presidency and passing the torch along to more pharma-friendly Denmark, whose role as a neutral broker may be questioned. Warsaw fought hard to overhaul pharmaceutical lawsβ¦
|
||||
You Might Like |
||||
